Rush University Medical Center, Rush Alzheimer's Disease Center, Chicago, IL; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL.
Rush University Medical Center, Rush Alzheimer's Disease Center, Chicago, IL; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL.
Am J Geriatr Psychiatry. 2022 Feb;30(2):174-181. doi: 10.1016/j.jagp.2021.05.007. Epub 2021 May 21.
Test the hypothesis that a higher level of purpose in life is associated with an older age of Alzheimer's dementia onset and later mortality.
Prospective cohort studies of aging and Alzheimer's dementia.
Community-based.
Two thousand five hundred fifty-eight older adults initially free of dementia underwent assessments of purpose in life and detailed annual clinical evaluations to document incident Alzheimer's dementia and mortality. General accelerated failure time models examined the relation of baseline purpose in life with age at Alzheimer's dementia diagnosis and mortality.
Purpose in life was assessed at baseline.
Alzheimer's dementia diagnosis was documented annually based on detailed clinical evaluations and mortality was documented via regular contacts and annual evaluations.
During a mean of 6.89 years of follow-up, 520 individuals were diagnosed with incident Alzheimer's dementia at a mean age of 88 (SD = 6.7; range: 64.1-106.5). They had a mean baseline level of purpose in life of 3.7 (SD = 0.47; range: 1-5). A higher level of purpose in life was associated with a considerably later age of dementia onset (estimate = 0.044; 95% CI: 0.023, 0.065); specifically, individuals with high purpose (90th percentile) developed Alzheimer's dementia at a mean age of about 95 compared to a mean age of about 89 for individuals with low purpose (10th percentile). Further, the estimated mean age of death was about 89 for individuals with high purpose compared to 85 for those with low purpose. Results persisted after controlling for sex and education.
Purpose in life delays dementia onset and mortality by several years. Interventions to increase purpose in life among older persons may increase healthspan and offer considerable public health benefit.
检验假设,即生活目标越高,阿尔茨海默病发病年龄越晚,死亡率越低。
老龄化和阿尔茨海默病的前瞻性队列研究。
社区为基础。
2558 名最初无痴呆的老年人接受了生活目标评估和详细的年度临床评估,以记录阿尔茨海默病的发病和死亡率。一般加速失效时间模型检查了基线生活目标与阿尔茨海默病诊断年龄和死亡率的关系。
生活目标在基线时进行评估。
每年根据详细的临床评估记录阿尔茨海默病的诊断,通过定期联系和年度评估记录死亡率。
在平均 6.89 年的随访期间,520 人被诊断患有阿尔茨海默病,平均年龄为 88 岁(标准差=6.7;范围:64.1-106.5)。他们的基线生活目标平均水平为 3.7(标准差=0.47;范围:1-5)。更高的生活目标与痴呆发病年龄明显推迟有关(估计值=0.044;95%置信区间:0.023,0.065);具体而言,高目标(90 百分位数)的个体在平均年龄约为 95 岁时患上阿尔茨海默病,而低目标(10 百分位数)的个体在平均年龄约为 89 岁时患上阿尔茨海默病。此外,高目标者的估计平均死亡年龄约为 89 岁,而低目标者为 85 岁。这些结果在控制性别和教育程度后仍然存在。
生活目标使痴呆发病和死亡推迟了数年。在老年人中增加生活目标的干预措施可能会延长健康寿命,并带来相当大的公共卫生效益。